She is compassionate, professional, and extremely knowledgeable
So I wrote a little thing for @MolMetab sciencedirect.com/science/articl As we now appreciate, GLP-1 can target multiple brain regions and neuronal populations to reduce food intake, and the clinical results are increasingly impressive #obesity The ongoing SELECT trial will be pivotal for the field sciencedirect.com/science/articl From very modest weight loss with exenatide twice daily, the GLP-1 field has learned, by titration, dose escalation, higher Cmax, and better molecules, to achieve clinically meaningful #weightloss #T2D #obesity More progress to come #obesity described here sciencedirect.com/science/articl Beyond semaglutide and tirzepatide, where might we find the next GLP-1-based advances in #weightloss #obesity Take a look at the slope of the lines for the combination of cagrilintide + semaglutide and make projections out to 52 weeks thelancet.com/journals/lance Join the conversation
Importantly, with a myosin inhibitor lowers HO, lessens arrhythmias, and protects CK function, pointing to workload reduction as a direct way to restore energetic balance
You're hitting mitochondrial health from two angles simultaneously: MOTS-C improves mitochondrial efficiency and increases fat oxidation NAD+ replenishes the coenzyme required for ATP synthesis For anyone over 40 who's training seriously, this pairing addresses two of the most significant age-related performance bottlenecks at once
